![](/img/cover-not-exists.png)
PUK9 SEVEN YEAR TRENDS OF PHARMACY BENEFIT ERYTHROPOIESIS-STIMULATING AGENT UTILIZATION AND COST CONSIDERATIONS OF CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS
F Vekeman, RA Bailey, F Laliberté, M Senbetta, RS McKenzie, P LefebvreVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72364-0
File:
PDF, 79 KB
english, 2010